DNLI vs NVST · rev $3.6M vs P/E 56, rev $1.44B
Denali Therapeutics Inc (DNLI) versus Envista Holdings Corp (NVST) — a side-by-side from cached financials, not a winner call.
Denali Therapeutics Inc (DNLI) is a biotechnology company listed on US.
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on US.
Latest reported DNLI revenue for 2026-06-30 was $3.6M. Net income was -$256.0M. DNLI currently screens at market cap $2.11B.
Latest reported NVST revenue for 2026-07-03 was $1.44B. Net income was $92.4M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
DNLI currently screens at market cap $2.11B. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
Not investment advice. Open the DNLI and NVST stock pages for the full models.
Not investment advice.